Literature DB >> 12873945

Neurotrophic factors can partially reverse morphological changes induced by mepivacaine and bupivacaine in developing sensory neurons.

Inas A M Radwan1, Shigeru Saito, Fumio Goto.   

Abstract

UNLABELLED: Both bupivacaine and mepivacaine induce morphological changes in growing neurons. We designed this study to investigate the role of some neurotrophic factors (NTFs) in supporting developing neurons exposed to the deleterious effects of these drugs. Dorsal root ganglia were isolated from chick embryos and exposed to either bupivacaine or mepivacaine. After 60 min of exposure, the culture media were replaced with fresh culture media free from local anesthetics. NTFs-brain-derived NTF, glial-derived NTF, or neurotrophin-3-were added to the replacement media, and the cells were examined up to 48 h after the washout. The growth cone collapse assay was applied by a quantitative method of assessment. When the replacement media were not supported by any NTF, the growth cone collapse values were significantly larger than the control values at 20 h after the washout of mepivacaine and 48 h after the washout of either bupivacaine or mepivacaine (P < 0.05). However, when any of the NTFs were used, the collapsing activity was significantly attenuated, and growth cone collapse values showed no statistically significant differences in comparison with the control values at these time points (P > 0.05). We conclude that several NTFs support the recovery of neurons after exposure to local anesthetics. The supporting effects of NTFs on the reversibility of mepivacaine-induced collapse tended to be more obvious than those seen after the bupivacaine washout. IMPLICATIONS: Three neurotrophic factors (NTFs) can partially support the reversibility of mepivacaine- and bupivacaine-induced growth cone collapse in growing primary cultured sensory neurons. The effect of NTFs is more apparent after mepivacaine than after bupivacaine washout.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873945     DOI: 10.1213/01.ane.0000068872.27693.ff

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Neurotoxicity of local anesthetics: effects on growing neurites and growth cones.

Authors:  Shigeru Saito
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

2.  Inhibiting EZH2 rescued bupivacaine-induced neuronal apoptosis in spinal cord dorsal root ganglia in mice.

Authors:  Jinwei Zheng; Junping Chen; Guorong Wu; Chaoshuang Wu; Ruichun Wang; Wei Wang
Journal:  J Anesth       Date:  2018-05-11       Impact factor: 2.078

3.  Effects of Zuogui Pill () and Yougui Pill () on the expression of brain-derived neurotrophic factor and cyclic adenosine monophosphate/protein kinase A signaling transduction pathways of axonal regeneration in model rats with experimental autoimmune encephalomyelitis.

Authors:  Yi-zhou Wang; Shuang Kou; Ling-yun Gu; Qi Zheng; Ming Li; Fang Qi; Hui Zhao; Lei Wang
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

4.  CaMK II γ down regulation protects dorsal root ganglion neurons from ropivacaine hydrochloride neurotoxicity.

Authors:  Xian-Jie Wen; Xiao-Hong Li; Heng Li; Hua Liang; Chen-Xiang Yang; Han-Bing Wang
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

Review 5.  Local anesthetic toxicity: acute and chronic management.

Authors:  Kenichi Sekimoto; Masaru Tobe; Shigeru Saito
Journal:  Acute Med Surg       Date:  2017-03-06

6.  Monosialoganglioside protects against bupivacaine-induced neurotoxicity caused by endoplasmic reticulum stress in rats.

Authors:  Benquan Liu; Jiemei Ji; Qing Feng; Xi Luo; Xiurong Yan; Yuxia Ni; Yajun He; Zhongxuan Mao; Jingchen Liu
Journal:  Drug Des Devel Ther       Date:  2019-02-19       Impact factor: 4.162

7.  Osthole-Mediated Inhibition of Neurotoxicity Induced by Ropivacaine via Amplification of the Cyclic Adenosine Monophosphate Signaling Pathway.

Authors:  WeiBing Wang; Hui Zhou; LaiBao Sun; MeiNa Li; FengJiao Gao; AiJiao Sun; XueNong Zou
Journal:  Dose Response       Date:  2022-03-31       Impact factor: 2.658

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.